Moderna-partnered gene therapy firm to lay off 68, including two execs


An Atlas Venture-backed startup developing gene therapies is laying off nearly half of its workforce.

Previous Richmond's Qnovia posts positive results in human trials for its smoking-cessation therapy
Next Local Infusion receives $10 million in funding for expansion, technology